Thorax 2015-01-01

Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland?

I Morris, M D Lyttle, R O'Sullivan, N Sargant, I J M Doull, C V E Powell

Index: Thorax 70(1) , 88-91, (2015)

Full Text: HTML

Abstract

During a prospective 10-week assessment period, 3238 children aged 1-16 years presented with acute wheeze to Paediatric Emergency Research in the UK and Ireland centres. 110 (3.3%) received intravenous bronchodilators. Intravenous magnesium sulfate (MgSO4) was used in 67 (60.9%), salbutamol in 61 (55.5%) and aminophylline in 52 (47.3%) of cases. In 35 cases (31.8%), two drugs were used together, and in 18 cases (16.4%), all three drugs were administered. When used sequentially the most common order was salbutamol, then MgSO4, then aminophylline. Overall, 30 different intravenous treatment regimens were used varying in drugs, dose, rate and duration. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Related Compounds

  • Salbutamol
  • magnesium sulfate...
  • magnesium sulfate
  • Albuterol sulfate
  • Aminophylline

Related Articles:

Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.

2015-03-01

[Drug Metab. Dispos. 43(3) , 344-52, (2015)]

Complementary usage of Rhodiola crenulata (L.) in chronic obstructive pulmonary disease patients: the effects on cytokines and T cells.

2015-04-01

[Phytother Res. 29(4) , 518-25, (2015)]

In vitro performance of spacers for aerosol delivery during adult mechanical ventilation.

2015-04-01

[J. Aerosol Med. Pulm. Drug Deliv. 28(2) , 130-6, (2015)]

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients.

2015-07-01

[Clin. Chem. Lab Med. 53 , 1259-64, (2015)]

More Articles...